Sunday, Nov 23rd
Last update09:25:11 AM GMT
In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
 Cases of infant botulism tied to the ByHeart infant formula recall have nearly tripled across 15... |
 This fall, multiple states including Maryland, Virginia, Tennessee and Wisconsin have reported outbreaks of hand, foot... | ||
 A federal judge officially approved drug maker Purdue Pharma’s latest deal to settle thousands of lawsuits... |
|
